Literature DB >> 26196054

Should antidepressant medication be used in the elderly?

Warren D Taylor1.   

Abstract

Late-life depression is a serious illness accompanied by medical morbidity, cognitive decline and risk of suicide. Antidepressant medications are a cornerstone of treatment for depressed elders. Although they are optimally provided in conjunction with psychotherapy, in many cases they are used alone. Recently, concern has developed over modern antidepressant medication, including concerns about their ultimate efficacy and particular risks that may be seen in older adult populations. Ultimately, antidepressant medications are effective for many individuals and continue to play an important role in treating depressed elders, although the potential risks must be weighed with the patient and their families. Current data do not support restriction of their use and untreated depression has serious negative health consequences. Patients need treatments with better efficacy and safety, including new pharmacological options and better access to and dissemination of nonpharmacological treatment.

Entities:  

Keywords:  adverse events; aging; antidepressant; depressive disorder; geriatrics; psychotropic medications; side effects; suicide; treatment

Mesh:

Substances:

Year:  2015        PMID: 26196054      PMCID: PMC4552589          DOI: 10.1586/14737175.2015.1070671

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  19 in total

Review 1.  Risk factors for suicide in later life.

Authors:  Yeates Conwell; Paul R Duberstein; Eric D Caine
Journal:  Biol Psychiatry       Date:  2002-08-01       Impact factor: 13.382

2.  Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine.

Authors:  Robert D Gibbons; C Hendricks Brown; Kwan Hur; John Davis; J John Mann
Journal:  Arch Gen Psychiatry       Date:  2012-06

3.  The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Authors:  G S Alexopoulos; I R Katz; C F Reynolds; D Carpenter; J P Docherty
Journal:  Postgrad Med       Date:  2001-10       Impact factor: 3.840

Review 4.  Cause or Effect? Selective Serotonin Reuptake Inhibitors and Falls in Older Adults: A Systematic Review.

Authors:  Marie Anne Gebara; Kim L Lipsey; Jordan F Karp; Maureen C Nash; Andrea Iaboni; Eric J Lenze
Journal:  Am J Geriatr Psychiatry       Date:  2014-11-25       Impact factor: 4.105

Review 5.  Clinical practice. Depression in the elderly.

Authors:  Warren D Taylor
Journal:  N Engl J Med       Date:  2014-09-25       Impact factor: 91.245

Review 6.  Depression and cognition in the elderly.

Authors:  Sophia Wang; Dan G Blazer
Journal:  Annu Rev Clin Psychol       Date:  2015-01-12       Impact factor: 18.561

7.  Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

Authors:  Enrico Tedeschini; Yeciel Levkovitz; Nadia Iovieno; Victoria E Ameral; J Craig Nelson; George I Papakostas
Journal:  J Clin Psychiatry       Date:  2011-12       Impact factor: 4.384

8.  Use of psychotherapy for depression in older adults.

Authors:  Wenhui Wei; Usha Sambamoorthi; Mark Olfson; James T Walkup; Stephen Crystal
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

9.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

10.  Does long term use of psychiatric drugs cause more harm than good?

Authors:  Peter C Gøtzsche; Allan H Young; John Crace
Journal:  BMJ       Date:  2015-05-12
View more
  2 in total

1.  Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics.

Authors:  Anna Levy; Wissam El-Hage; Djamila Bennabi; Etienne Allauze; Alexandra Bouvard; Vincent Camus; Philippe Courtet; Jean-Michel Dorey; Bruno Etain; Guillaume Fond; Jean-Baptiste Genty; Jérôme Holtzmann; Mathilde Horn; Marion Leboyer; Pierre-Michel Llorca; Manon Meyrel; Fanny Molière; Anne-Sophie Nguon; Jean Petrucci; Romain Rey; Raphaelle Richieri; Florian Stephan; Guillaume Vaiva; Michel Walter; Emmanuel Haffen; Bruno Aouizerate; Antoine Yrondi
Journal:  Front Psychiatry       Date:  2021-12-06       Impact factor: 4.157

2.  Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial.

Authors:  Giovanni Ostuzzi; Chiara Gastaldon; Angelo Barbato; Barbara D'Avanzo; Mauro Tettamanti; Igor Monti; Andrea Aguglia; Eugenio Aguglia; Maria Chiara Alessi; Mario Amore; Francesco Bartoli; Massimo Biondi; Paola Bortolaso; Camilla Callegari; Giuseppe Carrà; Rosangela Caruso; Simone Cavallotti; Cristina Crocamo; Armando D'Agostino; Pasquale De Fazio; Chiara Di Natale; Laura Giusti; Luigi Grassi; Giovanni Martinotti; Michela Nosé; Davide Papola; Marianna Purgato; Alessandro Rodolico; Rita Roncone; Lorenzo Tarsitani; Giulia Turrini; Elisa Zanini; Francesco Amaddeo; Mirella Ruggeri; Corrado Barbui
Journal:  Trials       Date:  2020-08-03       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.